Replies to post #151315 on Biotech Values

[bladerunner1717]

Don,

Wasn't there something in the literature that mentioned that Pona could actually prevent the T315i mutation from actually gaining traction? Wasn't this one of the arguments that Cortes (or someone on his team) made in respect to using Pona as front-line therapy?


Bladerunner